Transcatheter Pulmonary Valve (TPV) Therapy Market Size To Reach USD 66.4 Billion By 2026 Says Reports And Data

The current analysis of Reports and Data, the global transcatheter pulmonary valve therapy market was valued at USD 37.8 million in 2018 and is expected to reach USD 66.4 million by the year 2026, at a CAGR of 7.2 percent. Transcatheter Pulmonary Valve Therapy has come up as the treatment of choice in most congenital heart disease patients with degeneration of a previous right ventricular outflow tract repair. To avoid the need for repeat median sternotomy procedures, less invasive catheter-based interventions to treat pulmonary valve dysfunction have been developed over time.

The global market is driven by the rising incidence of congenital heart diseases and increasing awareness associated with TPV Therapy. For instance, in the United States, the incidence of congenital heart defects ranges between 4 to10 cases per 1,000, clustering around 8 cases per 1,000 live births. Continental variations in birth prevalence have been observed, from about 6.9 cases per 1000 births in Europe to 9.3 cases per 1000 births in Asia. However, the relationship between valve size and balloon waist may reflect selection and procedural bias, which is likely to hinder the market growth

Key participants include:

Medtronic, Edward Lifesciences, Cryolife Inc, and Venus Medtech.

Get a Sample Copy of the Transcatheter Pulmonary Valve (TPV) Therapy Market Report @ https://www.reportsanddata.com/sample-enquiry-form/1067

The research segments the market based on product type, applications and end-use. It profiles the key players of the business and their individual contribution to the global economy. The report focuses on significant investments, business ventures, mergers, acquisitions, collaborations along with the technological developments in the field. It also evaluates the upcoming and niche areas in the business. The researcher aims to offer expert insights related to the industry and the new opportunities available in the market.

For the purpose of this report, Reports and Data has segmented the global transcatheter pulmonary valve therapy market on the basis of product, piling method and region:

Type (Revenue, USD Million; 2016–2026)

Balloon expanded
Self-expanded Transcatheter Valve

Application Outlook (Revenue, USD Million; 2016–2026)

Hospitals
Cardiology Centers
Others

Regional Outlook (Revenue in USD Million; 2020–2026)

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)

Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/1067

Further key findings from the report suggest

Transcatheter Pulmonary Valve Therapy market is rising at a high growth rate of 7.2 percent in Asia Pacific followed by North America and Europe. High incidence of cardiovascular diseases will drive the demand for the market during forecast period across all regions.

The valuation for balloon expanded transcatheter Valve market was USD 30.5 million in 2017 and is expected to grow to USD 53.0 million by 2026. Benefits associated with transcatheter pulmonary Valve is the key factor supporting the increasing adoption of the theraphy and consequently contributing to the market growth.

Asia Pacific is expected to witness a CAGR of 12.9 percent in the forecast period. Emerging markets such China and Japan are likely to witness high growth

Regional reimbursement scenario is another key regulatory factor for adoption and growth of transcatheter pulmonary valve therapy in the region…Continued

Access Report Details @ https://www.reportsanddata.com/report-detail/transcatheter-pulmonary-valves-tpv-therapy-market

Reasons to buy Transcatheter Pulmonary Valve (TPV) Therapy Market Report: –

Information provided in the report assists companies in making well-informed executive decisions with a comprehensive understanding of the Transcatheter Pulmonary Valve (TPV) Therapy market scenario and trends.

Assists companies in implementing lucrative expansion strategies by offering information relating to the projected fluctuations in sales performance and supplier prices.

Enables IT enterprises in capitalizing on the latest market trends and accurate insights into the Transcatheter Pulmonary Valve (TPV) Therapy Market, arming them with essential information and other significant concerns of the industry.

It allows readers to make favorable investments by tracing the substantial focus areas highlighted by survey takers in 2018.

Have questions regarding this Report? You can consult with an expert at @ https://www.reportsanddata.com/speak-to-analyst-form/1067

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.